Riskpilot← Back to searchSign inGet full accessLÆGEHUSET I PADBORG ApS
APSActiveCVR 12671881Trækobbel 6Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 1988— employees
Revenue 2025
DKK 804K
0% vs 2024
EBITDA margin
100.0%
0% vs 2024
Equity ratio
31.1%
Financial strength
Net profit 2025
DKK 532K
+1% vs 2024
| Revenue | DKK 804K | +0% |
| EBITDA | DKK 804K | +0% |
| Net profit | DKK 532K | +1% |
| Total assets | DKK 2,4M | -8% |
| Equity | DKK 732K | +1% |
| Employees | — | — |
Legal name
LÆGEHUSET I PADBORG ApS
CVR number
12671881
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
1. december 1988
Share capital
DKK 200.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to bestyrelsesmedlemmer i forening med en direktør
Company purpose
Selskabets formål er udlejning af fast ejendom til brug for lægehus og herudover investering og financiering samt anden efter bestyrelsens skøn hermed beslægtet virksomhed
Address
Trækobbel 6
Phone
+4574671375
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 680 | 697 | 692 | 802 | 804 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 680 | 697 | 692 | 802 | 804 |
| Depreciation & amort. | -55 | -55 | -55 | -55 | -55 |
| EBIT | 624 | 642 | 637 | 746 | 749 |
| Net financials | -49 | -46 | -43 | -53 | -47 |
| Profit before tax | 575 | 595 | 594 | 693 | 702 |
| Tax | 138 | 143 | 143 | 166 | 169 |
| Net profit | 437 | 453 | 452 | 527 | 532 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.585 | 2.489 | 2.448 | 2.554 | 2.358 |
| Equity | 637 | 653 | 652 | 727 | 732 |
| Long-term debt | 1.815 | 1.698 | 1.579 | 1.458 | 1.335 |
| Short-term debt | 133 | 139 | 217 | 369 | 291 |
| Total debt | 1.948 | 1.837 | 1.796 | 1.826 | 1.626 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
31.1%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
72.7%
This company
18.4%
Market median
+295% vs market
20212025
Net profit margin
66.2%
This company
8.1%
Market median
+717% vs market
20212025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20212025
Debt / equity
2.22×
This company
0.62×
Market median
-258% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
ET | Audit | 1988 – 1989 |
| Audit | 1988 – 1993 | |
SS Management | Management | 1988 – 1989 |
JM Management | Management | 1988 – 1999 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Chairman | 1988 – 1995 | |
| Board of Directors | 1988 – 2000 | |
| Board of Directors | 1988 – 2012 | |
| Board of Directors | 1988 – 1989 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10–14.99% | 10–14.99% | 2006 | |
| Individual | 10–14.99% | 10–14.99% | 2022 | |
| Individual | 10–14.99% | 10–14.99% | 2016 | |
| Individual | 10–14.99% | 10–14.99% | 2006 | |
| Individual | 10–14.99% | 10–14.99% | 2024 | |
| Individual | 10–14.99% | 10–14.99% | 2023 | |
| Individual | 10–14.99% | 10–14.99% | 2021 | |
| Individual | 10–14.99% | 10–14.99% | 2006 | |
| Individual | 5–9.99% | 5–9.99% | 2006 | |
| Individual | 10–14.99% | 10–14.99% | 2006 | |
| Individual | 10–14.99% | 10–14.99% | 2006 | |
| Individual | 10–14.99% | 10–14.99% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LÆGEHUSET I PADBORG ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| STATSAUTORISERET REVISIONSAKTIESELSKAB AF 1. JULI 1998 | Audit | 0 companies |
| Susanne Saul Stakemann | Management | 0 companies |
| Jens Møldrup | Management | 0 companies |
| Torben Sørensen | Chairman | 0 companies |
| Kirsten Munk Møldrup | Board of Directors | 0 companies |
| Marius Nørgård | Board of Directors | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |